Literature DB >> 15790736

Modulation of gingival fibroblast minocycline accumulation by biological mediators.

J D Walters1, R J Nakkula, P Maney.   

Abstract

Gingival fibroblasts actively accumulate tetracyclines, thereby enhancing their redistribution from blood to gingiva. Since growth factors and pro-inflammatory cytokines regulate many fibroblast activities, they could potentially enhance fibroblast minocycline accumulation. To test this hypothesis, we treated gingival fibroblast monolayers for 1 or 6 hours with platelet-derived growth factor-BB (PDGF), fibroblast growth factor-2 (FGF), transforming growth factor-beta1 (TGF), or tumor necrosis factor-alpha (TNF). Minocycline uptake was assayed at 37 degrees by a fluorescence method. All 4 factors significantly enhanced minocycline uptake (P < or = 0.008, ANOVA), primarily by increasing the affinity of transport. Treatment for 6 hours with 10 ng/mL FGF, PDGF, TGF, or TNF enhanced fibroblast minocycline uptake by 19% to 25%. Phorbol myristate acetate enhanced fibroblast minocycline uptake by 28%, suggesting that protein kinase C plays a role in up-regulating transport. These effects on transport provide a mechanism by which systemic tetracyclines could be preferentially distributed to gingival wound or inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790736      PMCID: PMC2241671          DOI: 10.1177/154405910508400405

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

Review 1.  Biological mediators for periodontal regeneration.

Authors:  D L Cochran; J M Wozney
Journal:  Periodontol 2000       Date:  1999-02       Impact factor: 7.589

2.  Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.

Authors:  Q Yang; R J Nakkula; J D Walters
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

3.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Characterization of fibroblasts derived from human periodontal ligament and gingiva.

Authors:  A Mariotti; D L Cochran
Journal:  J Periodontol       Date:  1990-02       Impact factor: 6.993

5.  Virulence Factors of the Periodontopathogen Actinobacillus actinomycetemcomitans.

Authors:  P Fives-Taylor; D Meyer; K Mintz
Journal:  J Periodontol       Date:  1996-03       Impact factor: 6.993

Review 6.  Modulation of the host response in periodontal therapy.

Authors:  Richard J Oringer
Journal:  J Periodontol       Date:  2002-04       Impact factor: 6.993

7.  Fibroblast growth factor stimulates protein kinase C in quiescent 3T3 cells without Ca2+ mobilization or inositol phosphate accumulation.

Authors:  E Nånberg; C Morris; T Higgins; F Vara; E Rozengurt
Journal:  J Cell Physiol       Date:  1990-05       Impact factor: 6.384

Review 8.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

Authors:  D T Graves; D Cochran
Journal:  J Periodontol       Date:  2003-03       Impact factor: 6.993

9.  Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts.

Authors:  Vidar A T Thorsen; Marta Vorland; Bodil Bjørndal; Ove Bruland; Holm Holmsen; Johan R Lillehaug
Journal:  Biochim Biophys Acta       Date:  2003-06-10

10.  Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies.

Authors:  L A Christersson; B Albini; J J Zambon; U M Wikesjö; R J Genco
Journal:  J Periodontol       Date:  1987-08       Impact factor: 6.993

View more
  6 in total

1.  Accumulation of non-steroidal anti-inflammatory drugs by gingival fibroblasts.

Authors:  M M Zavarella; O Gbemi; J D Walters
Journal:  J Dent Res       Date:  2006-05       Impact factor: 6.116

2.  Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection.

Authors:  Diego Romero-Perez; Eduardo Fricovsky; Katrina Go Yamasaki; Michael Griffin; Maraliz Barraza-Hidalgo; Wolfgang Dillmann; Francisco Villarreal
Journal:  J Am Coll Cardiol       Date:  2008-09-23       Impact factor: 24.094

3.  Minocycline hydrochloride nanoliposomes inhibit the production of TNF-α in LPS-stimulated macrophages.

Authors:  D Liu; P S Yang
Journal:  Int J Nanomedicine       Date:  2012-08-31

4.  Proteomic analysis of the anti-inflammatory action of minocycline.

Authors:  Christopher R Dunston; Helen R Griffiths; Peter A Lambert; Susan Staddon; Ann B Vernallis
Journal:  Proteomics       Date:  2010-12-06       Impact factor: 3.984

5.  Effect of diode laser combined with minocycline hydrochloride in nonsurgical periodontal therapy: a randomized clinical trial.

Authors:  Congchong Yang; Xikai Wang; Yanli Wang
Journal:  BMC Oral Health       Date:  2022-03-14       Impact factor: 2.757

6.  In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy.

Authors:  Jan-Luca Schmid; Martin Kirchberg; Sandra Sarembe; Andreas Kiesow; Anton Sculean; Karsten Mäder; Mirko Buchholz; Sigrun Eick
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.